COMMUNIQUÉS West-GlobeNewswire

AnaptysBio Presents Updated ANB020 and ANB019 Clinical Data at the 2018 EAACI Congress

29/05/2018 - 14:30

Blood eosinophil level reduction consistent with clinical efficacy in ANB020 Phase 2a atopic dermatitis trial ANB020-mediated eosinophil reduction is aligned with genotypic data from prior human IL-33 loss-of-function [...]

Delcath Systems to Present at the 8th Annual LD Micro Invitational

29/05/2018 - 14:30

NEW YORK, May 29, 2018 (GLOBE NEWSWIRE) -- Delcath Systems, Inc. (OTCQB:DCTHD), an interventional oncology company focused on the treatment of primary and metastatic liver cancers, today announced that it will be [...]

Spring Bank to Present at Jefferies 2018 Global Healthcare Conference

29/05/2018 - 14:30

HOPKINTON, Mass., May 29, 2018 (GLOBE NEWSWIRE) -- Spring Bank Pharmaceuticals, Inc. (NASDAQ: SBPH ), a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of viral infections, [...]

Avinger to Present at the 8th Annual LD Micro Invitational

29/05/2018 - 14:30

REDWOOD CITY, Calif., May 29, 2018 (GLOBE NEWSWIRE) -- Avinger, Inc. (Nasdaq: AVGR ), a leading developer of innovative treatments for peripheral artery disease (PAD), announced today that it will be presenting at the 8 [...]

Viveve to Present at Jefferies Global Healthcare Conference

29/05/2018 - 14:24

ENGLEWOOD, Colo., May 29, 2018 (GLOBE NEWSWIRE) -- Viveve Medical, Inc. ("Viveve") (NASDAQ: VIVE ), a medical technology company focused on women's intimate health, today announced that Scott Durbin, chief executive [...]

MPX Raises US$40 Million Secured Convertible Loan to Fund Capacity Development of MPX Assets and Acquisitions

29/05/2018 - 14:20

TORONTO, May 29, 2018 (GLOBE NEWSWIRE) -- MPX Bioceutical Corporation (“ MPX ” or the “ Company ”) (CSE:MPX) (OTC:MPXEF) is pleased to announce that it has successfully completed a US$40,000,000 secured convertible [...]

iKang Enters into Amendment to Merger Agreement for Going Private Transaction

29/05/2018 - 14:16

BEIJING, May 29, 2018 (GLOBE NEWSWIRE) -- iKang Healthcare Group, Inc. (“iKang” or the “Company”) (Nasdaq: KANG ), a major provider in China’s fast growing private preventive healthcare services market, today announced [...]

Avid Bioservices to Participate at BIO International Convention 2018

29/05/2018 - 14:05

-- Corporate Booth to Include Virtual Tour of Myford Late-Stage Clinical and Commercial Biomanufacturing Facility Highlighting Immediately Available 2,000-Liter Scale Bioreactor Capacity -- -- Company’s Newly Appointed [...]

Catalyst Pharmaceuticals Announces FDA Acceptance of NDA and Priority Review Status for Firdapse® (Amifampridine Phosphate) for Lambert-Eaton Myasthenic Syndrome

29/05/2018 - 14:03

--PDUFA Date Set for November 28, 2018 CORAL GABLES, Fla., May 29, 2018 (GLOBE NEWSWIRE) -- Catalyst Pharmaceuticals, Inc. (Catalyst) (Nasdaq: CPRX ), a biopharmaceutical company focused on developing and [...]

BIOLIFE4D Establishes Operations in Houston as Part of Commercialization Strategy for Life-Saving 3D Bioprinting Technology

29/05/2018 - 14:02

Houston location provides access to state-of-the-art equipment and support, and close proximity to world class academic research facilities within local university medical and science centers, as Company continues [...]

AMAG Pharmaceuticals to Present at Upcoming Investor Conference

29/05/2018 - 14:00

WALTHAM, Mass., May 29, 2018 (GLOBE NEWSWIRE) -- AMAG Pharmaceuticals, Inc. (NASDAQ: AMAG ) today announced that management will participate in the Jefferies 2018 Healthcare Conference on Tuesday, June 5 th at 3:30 p.m [...]

Abiomed to Present at the Jefferies 2018 Healthcare Conference

29/05/2018 - 14:00

DANVERS, Mass., May 29, 2018 (GLOBE NEWSWIRE) -- Abiomed, Inc. (NASDAQ: ABMD ), a leading provider of breakthrough heart support technologies, today announced that Michael R. Minogue, Chairman, President and Chief [...]

Albireo to Present at Jefferies 2018 Global Healthcare Conference

29/05/2018 - 14:00

BOSTON, May 29, 2018 (GLOBE NEWSWIRE) -- Albireo Pharma, Inc. (Nasdaq: ALBO ), a clinical-stage orphan pediatric liver disease company developing novel bile acid modulators, today announced that Ron Cooper, President [...]

BioCryst Announces Presentation of Additional Analyses of the APeX-1 Clinical Trial of BCX7353 at the 2018 European Academy of Allergy and Clinical Immunology (EAACI) Congress

29/05/2018 - 14:00

RESEARCH TRIANGLE PARK, N.C., May 29, 2018 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (NASDAQ: BCRX ), a pharmaceutical company focused on the development and commercialization of treatments for rare diseases, [...]

CASMED to Present at the 8th Annual LD Micro Invitational Conference on June 5

29/05/2018 - 14:00

BRANFORD, Conn., May 29, 2018 (GLOBE NEWSWIRE) -- CAS Medical Systems, Inc. (NASDAQ: CASM ) (CASMED), a leader in medical devices for non-invasive patient monitoring, announces that Thomas M. Patton, President and Chief [...]

SCOUTCare™ Honored with Prestigious Aster Awards for Healthcare Communications

29/05/2018 - 14:00

Cianna Medical Continues to Expand Use of Innovative SAVI SCOUT® Technology and Supports Hospitals’ Mission to Become Wire-free Providers ALISO VIEJO, Calif., May 29, 2018 (GLOBE NEWSWIRE) -- Cianna Medical, Inc., the [...]

UroGen Pharma to Present at the Jefferies 2018 Global Healthcare Conference

29/05/2018 - 14:00

RA’ANANA, Israel and NEW YORK, May 29, 2018 (GLOBE NEWSWIRE) -- UroGen Pharma Ltd. (Nasdaq: URGN ), a clinical-stage biopharmaceutical company developing treatments to address unmet needs in the field of urology, with a [...]

FDA Clears Development Pathway for NexoBrid® for Sulfur Mustard Injuries

29/05/2018 - 14:00

YAVNE, Israel, May 29, 2018 (GLOBE NEWSWIRE) -- MediWound Ltd. (Nasdaq: MDWD ), a fully-integrated biopharmaceutical company bringing innovative therapies to address unmet needs in severe burn and wound management, [...]

Savara Provides Update on Case Reports of Inhaled Granulocyte-Macrophage Colony Stimulating Factor for the Treatment of Nontuberculous Mycobacteria Infection

29/05/2018 - 14:00

AUSTIN, Texas, May 29, 2018 (GLOBE NEWSWIRE) -- Savara, Inc. (NASDAQ: SVRA ), an orphan lung disease company, today provided an update on two case reports exploring the use of aerosolized granulocyte-macrophage colony [...]